Market Research Logo

Global Peripheral Artery Disease Market Report: 2016 Edition

Global Peripheral Artery Disease Market Report: 2016 Edition

Peripheral Artery Disease (PAD) is a medical condition in which plaque builds up on the artery walls, blocking the flow of oxygen-rich blood to the legs, stomach, and arms. Major factors causing PAD are smoking, diabetes, high blood pressure, abnormal cholesterol levels, advancing age and a personal history of vascular disease. The earliest symptom of Peripheral Artery Disease is a cramp-like muscular discomfort called intermittent claudication, while numbness, tingling, weakness or fatigue is also experienced. Patients with severe PAD often develop ulcers in their legs and feet. Its prevention involves a lifelong program involving certain lifestyle changes like healthy eating and physical exercise.

Medical Diagnosis of PAD includes methods like Ankle-Brachial Index, Ultrasound, Angiography, Catheter Angiography and Blood Tests. There are a number of treatment options for the disease that can be used alone or mixed with other devices. They are Percutaneous Trans Luminal Angioplasty (PTA), Drug-Coated Balloons, Stents, Drug-Eluting Stents, Arterial Bypass and Atherectomy.

The global peripheral artery disease market, bolstered by rising healthcare expenditures has seen a persistent growth in the last few years. The report provides an overview of the entire global peripheral artery disease market including the devices market and the atherectomy market. Certain key trends like increased used of DCBs and favorable reimbursements have also been discussed. Growth drivers including rising ageing population, obesity and healthcare expenditures find mention in the report along with the challenges and limitations including underpenetrated treatment market for PAD.

Competition in the global peripheral artery disease market is rather fragmented with big companies recording excellent profits while smaller companies continue to gain prevalence through research and innovation.

The report has forecasted future trend in the global Peripheral Artery Disease market by combining SPSS Inc.’s data integration and analysis capabilities. Regression models have been created by employing various significant variables that have an impact on the market. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables, and tests.


1. Market Overview
1.1 Introduction
Table 1: Types of Atherosclerosis Diseases
1.2 Causes of Peripheral Artery Disease
Table A: Factors Causing Peripheral Artery Disease
1.3 Prevention
1.4 Diagnosis
1.4.1 Symptoms
1.4.2 Medical Diagnosis
1.5 Treatment Options for Peripheral Artery Disease
1.5.1 Percutaneous Trans Luminal Angioplasty (PTA)
1.5.2 Drug-Coated Balloons (DCBs)
1.5.3 Stents
1.5.4 Drug-Eluting Stents (DES)
1.5.5 Arterial Bypass
1.5.6 Atherectomy
2. Global Peripheral Artery Disease Market
2.1 Global Peripheral Artery Disease Market by Value
Table 2: Global Peripheral Artery Disease Market by Value (2008-2015E)
2.2 Global Peripheral Artery Disease Prevalence
Table 3: Global Peripheral Artery Disease Prevalence by Region (2015)
2.3 Global Peripheral Artery Devices Market
2.3.1 Peripheral Artery Devices Market by Treatment
Table 4: Treatment Mix for Peripheral Intervention Cases (2015)
2.3.2 Drug Eluting Stents Market by Volume
Table 5: Global Drug-Eluting Stents Market by Volume (2008-2015E)
2.3.3 Drug Eluting Stents Market by Geography
Table 6: Global Drug-Eluting Stents Volume by Geography (2008-14)
3. Regional Peripheral Artery Disease Market
3.1 The U.S.
3.1.1 The U.S. PAD Diagnosed Cases
Table 7: Diagnosed PAD Cases in the U.S. (2012-2015E)
3.1.2 The U.S. PAD Interventions and Penetration
Table 8: PAD Interventions in the U.S (2012-2015E)
Table 9: The US Interventional Treatment Methods by Market Share (2015)
3.1.3 The U.S. DCB Procedures and Penetration
Table 10: DCB Procedures and Penetration Rate in the U.S. (2014-2015E)
3.1.4 The U.S. DCB Market by Value
Table 11: The U.S. DCB Market by Value (2014-2018E)
3.1.5 The U.S. Stents/PTA Procedures and Penetration
Table 12: Stents/PTA Procedures and Penetration Rate in the U.S. (2014-2015E)
3.2 The European Union
Table 13: Diagnosed PAD Cases in the EU (2012-2015E)
3.2.2 The EU PAD Intervention and Penetration
Table 14: PAD Interventions in the EU (2012-2015E)
4. Peripheral Atherectomy Market
4.1 Global Peripheral Atherectomy Market
Table 15: Global Peripheral Atherectomy Market (2012-2015E)
4.2 Regional Peripheral Atherectomy Market
Table 16: Total Peripheral Atherectomy Market in the U.S. (2012-2015E)
Table 17: Total EU Peripheral Atherectomy Market (2012-2015E)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Rising Ageing Population
Table 18: Global Population Over 50 Years of Age (2010-2015E)
5.1.2 Rising Proportion of Health Expenditure in Emerging Economies
Table 19: Health Expenditures of China and Brazil (2008-2014)
5.1.3 Increasing Obese Population
Table 20: Global Obese Population (2009-2014)
5.1.4 Rise of Drug-Coated Balloons in the US
5.1.5 Escalating Healthcare Spending
Table 21: Global Healthcare Spending (2007-2014)
5.2 Trends
Table 22: DCB use by Application Method (2015)
5.2.2 DCB the Preferred Treatment for ISR
Table 23: Treatment Mix for ISR Lesions (2014/2015)
5.2.3 Favorable Atherectomy Reimbursements
5.3 Challenges
Table 24: Percentage of PAD device Usage hurt by DCBs (2015)
5.3.3 Limitation of Peripheral Interventions
6. Competitive Landscape
6.1 Global Peripheral Artery Disease Market by Company
Table 25: Global PAD Top Companies Revenue Comparison (2015)
Table 26: Global PAD Top Companies CAGR Comparison (2011-2015)
6.2 Global Peripheral Atherectomy Market by Company
Table 27: Global Peripheral Atherectomy Market by Company (2015E)
6.3 The US Peripheral Atherectomy Market Share
Table 28: The US Peripheral Atherectomy Market (2015)
7. Company Profiles
7.1 Cardiovascular Systems Inc.
7.1.1 Business Overview
Table B: CSII’s FDA Approved Peripheral Artery Disease Systems
7.1.2 Financial Overview
Table 29: CSII Revenue and Net Income (2011-2015*)
7.1.3 Business Strategies
7.2 Medtronic Plc.
7.2.1 Business Overview
Table 30: Medtronic’s Market Share by Business Unit (2015*)
7.2.2 Financial Overview
Table 31: MDT Revenue and Net Income (2011-2015*)
7.2.3 Business Strategies
7.3 Spectranetics Corp.
7.3.1 Business Overview
Table C: Spectranetics Product by Segment
Table 32: SPNC’s Revenue Share by Segment (2015)
7.3.2 Financial Overview
Table 33: SPNC Revenue and Net Income (2011-2015)
7.3.3 Business Strategies
7.4 Boston Scientific Corp.
7.4.1 Business Overview
Table 34: BSX Sales by Product Category (2014)
7.4.2 Financial Overview
Table 35: BSX Revenue and Net Income (2011-2015)
7.4.3 Business Strategies
8. Market Outlook
8.1 Global Peripheral Artery Disease Market Forecast
Table 36: Global Peripheral Artery Disease Market Forecast (2014-2018F)
8.2 Forecast Methodology
Table D: Dependent & Independent Variables (2010– 2014)
8.2.1 Dependent and Independent Variables
8.2.2 Correlation Analysis
Table E: Correlation Matrix
Table F: Model Summary – Coefficient of Determination
Table G: Regression Coefficients Output

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report